Citadel Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.17M Buy
302,156
+66,368
+28% +$1.13M ﹤0.01% 1885
2025
Q1
$15M Sell
235,788
-382,033
-62% -$24.4M ﹤0.01% 1034
2024
Q4
$75.1M Sell
617,821
-308,398
-33% -$37.5M 0.01% 365
2024
Q3
$116M Buy
926,219
+150,398
+19% +$18.8M 0.02% 196
2024
Q2
$123M Sell
775,821
-747,256
-49% -$118M 0.02% 195
2024
Q1
$197M Buy
1,523,077
+180,347
+13% +$23.3M 0.04% 103
2023
Q4
$129M Buy
1,342,730
+114,756
+9% +$11.1M 0.03% 174
2023
Q3
$149M Buy
1,227,974
+337,261
+38% +$40.9M 0.03% 134
2023
Q2
$102M Buy
890,713
+637,299
+251% +$73M 0.02% 225
2023
Q1
$34.9M Sell
253,414
-152,067
-38% -$21M 0.01% 594
2022
Q4
$52.5M Buy
405,481
+303,359
+297% +$39.3M 0.01% 421
2022
Q3
$11.3M Sell
102,122
-471,201
-82% -$52.1M ﹤0.01% 1183
2022
Q2
$43M Sell
573,323
-21,965
-4% -$1.65M 0.01% 438
2022
Q1
$46.5M Buy
595,288
+278,861
+88% +$21.8M 0.01% 465
2021
Q4
$28.5M Sell
316,427
-455,377
-59% -$41M 0.01% 743
2021
Q3
$71.4M Buy
771,804
+59,445
+8% +$5.5M 0.01% 316
2021
Q2
$55.4M Buy
712,359
+466,488
+190% +$36.3M 0.01% 448
2021
Q1
$18.3M Buy
245,871
+228,789
+1,339% +$17.1M ﹤0.01% 992
2020
Q4
$2.91M Sell
17,082
-122,029
-88% -$20.8M ﹤0.01% 2209
2020
Q3
$19.5M Buy
139,111
+75,309
+118% +$10.6M 0.01% 760
2020
Q2
$10.2M Sell
63,802
-68,500
-52% -$11M ﹤0.01% 1069
2020
Q1
$12.9M Buy
132,302
+50,585
+62% +$4.95M 0.01% 859
2019
Q4
$10.5M Sell
81,717
-249,913
-75% -$32.2M ﹤0.01% 1137
2019
Q3
$25M Buy
331,630
+316,262
+2,058% +$23.8M 0.01% 705
2019
Q2
$2.34M Sell
15,368
-155,342
-91% -$23.6M ﹤0.01% 2297
2019
Q1
$20.3M Buy
170,710
+167,483
+5,190% +$20M 0.01% 741
2018
Q4
$352K Sell
3,227
-283,984
-99% -$31M ﹤0.01% 3472
2018
Q3
$46.4M Sell
287,211
-151,103
-34% -$24.4M 0.02% 424
2018
Q2
$57.9M Buy
438,314
+389,927
+806% +$51.5M 0.03% 331
2018
Q1
$3.59M Sell
48,387
-401,315
-89% -$29.7M ﹤0.01% 1511
2017
Q4
$25M Sell
449,702
-1,585,488
-78% -$88.2M 0.02% 598
2017
Q3
$92.3M Buy
2,035,190
+1,032,421
+103% +$46.8M 0.07% 172
2017
Q2
$33.8M Buy
1,002,769
+394,041
+65% +$13.3M 0.03% 421
2017
Q1
$18M Buy
608,728
+155,768
+34% +$4.61M 0.02% 656
2016
Q4
$12.4M Sell
452,960
-188,779
-29% -$5.18M 0.01% 664
2016
Q3
$39.4M Buy
641,739
+476,996
+290% +$29.3M 0.04% 299
2016
Q2
$3.14M Sell
164,743
-1,357,309
-89% -$25.9M ﹤0.01% 1240
2016
Q1
$29.7M Buy
1,522,052
+707,906
+87% +$13.8M 0.04% 338
2015
Q4
$31.4M Sell
814,146
-103,901
-11% -$4.01M 0.03% 449
2015
Q3
$29.5M Buy
918,047
+805,205
+714% +$25.9M 0.03% 491
2015
Q2
$3.43M Buy
112,842
+95,311
+544% +$2.9M ﹤0.01% 1442
2015
Q1
$233K Sell
17,531
-16,447
-48% -$219K ﹤0.01% 3041
2014
Q4
$492K Buy
33,978
+5,432
+19% +$78.7K ﹤0.01% 2570
2014
Q3
$602K Buy
28,546
+24,138
+548% +$509K ﹤0.01% 2331
2014
Q2
$131K Buy
+4,408
New +$131K ﹤0.01% 2927
2014
Q1
Hold
0
3737
2013
Q4
Sell
-1,705
Closed -$81K 3200
2013
Q3
$81K Sell
1,705
-99,089
-98% -$4.71M ﹤0.01% 2530
2013
Q2
$3.84M Buy
+100,794
New +$3.84M 0.01% 1118